Variant report
Variant | rs679625 |
---|---|
Chromosome Location | chr11:58648231-58648232 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:29)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:29 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:58648139-58648384 | HepG2 | liver: | n/a | chr11:58648287-58648300 |
2 | EP300 | chr11:58648032-58648406 | HepG2 | liver: | n/a | n/a |
3 | FOXA1 | chr11:58648036-58648475 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr11:58648024-58648392 | HepG2 | liver: | n/a | chr11:58648287-58648300 |
5 | FOXA1 | chr11:58647976-58648544 | HepG2 | liver: | n/a | n/a |
6 | HNF4A | chr11:58648110-58648399 | HepG2 | liver: | n/a | chr11:58648324-58648339 chr11:58648325-58648338 chr11:58648326-58648338 chr11:58648324-58648339 chr11:58648326-58648338 chr11:58648324-58648339 chr11:58648324-58648339 chr11:58648326-58648338 chr11:58648324-58648339 |
7 | MYC | chr11:58648181-58648368 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | CEBPB | chr11:58648183-58648434 | A549 | lung: | n/a | chr11:58648287-58648300 |
9 | FOXA1 | chr11:58647950-58648372 | HepG2 | liver: | n/a | n/a |
10 | FOXA1 | chr11:58648027-58648516 | HepG2 | liver: | n/a | n/a |
11 | TEAD4 | chr11:58648024-58648594 | HepG2 | liver: | n/a | n/a |
12 | FOXA2 | chr11:58647992-58648393 | HepG2 | liver: | n/a | n/a |
13 | HNF4G | chr11:58648037-58648391 | HepG2 | liver: | n/a | chr11:58648324-58648339 chr11:58648325-58648338 chr11:58648326-58648338 chr11:58648324-58648339 chr11:58648326-58648338 chr11:58648324-58648339 chr11:58648324-58648339 chr11:58648326-58648338 |
14 | HDAC2 | chr11:58648138-58648463 | HepG2 | liver: | n/a | n/a |
15 | HDAC2 | chr11:58648041-58648453 | HepG2 | liver: | n/a | n/a |
16 | ARID3A | chr11:58648155-58648546 | HepG2 | liver: | n/a | n/a |
17 | JUND | chr11:58648146-58648342 | HepG2 | liver: | n/a | n/a |
18 | EP300 | chr11:58648140-58648429 | HepG2 | liver: | n/a | n/a |
19 | HNF4A | chr11:58648083-58648385 | HepG2 | liver: | n/a | chr11:58648324-58648339 chr11:58648325-58648338 chr11:58648326-58648338 chr11:58648324-58648339 chr11:58648326-58648338 chr11:58648324-58648339 chr11:58648324-58648339 chr11:58648326-58648338 chr11:58648324-58648339 |
20 | CEBPB | chr11:58648118-58648482 | HepG2 | liver: | n/a | chr11:58648287-58648300 |
21 | RCOR1 | chr11:58648138-58648400 | HepG2 | liver: | n/a | n/a |
22 | JUN | chr11:58648179-58648402 | HepG2 | liver: | n/a | n/a |
23 | GATA3 | chr11:58648189-58648326 | SH-SY5Y | brain: | n/a | n/a |
24 | SP1 | chr11:58648000-58648522 | HepG2 | liver: | n/a | n/a |
25 | HNF4G | chr11:58648088-58648436 | HepG2 | liver: | n/a | chr11:58648324-58648339 chr11:58648325-58648338 chr11:58648326-58648338 chr11:58648324-58648339 chr11:58648326-58648338 chr11:58648324-58648339 chr11:58648324-58648339 chr11:58648326-58648338 |
26 | CEBPB | chr11:58648074-58648804 | HepG2 | liver: | n/a | chr11:58648287-58648300 |
27 | EP300 | chr11:58648078-58648464 | HepG2 | liver: | n/a | n/a |
28 | FOXA2 | chr11:58647895-58648633 | HepG2 | liver: | n/a | n/a |
29 | MYBL2 | chr11:58647971-58648550 | HepG2 | liver: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GLYATL1P2 | TF binding region |
rs_ID | r2[population] |
---|---|
rs10792184 | 0.84[CEU][hapmap] |
rs10792185 | 0.84[CEU][hapmap] |
rs10896825 | 0.84[CEU][hapmap] |
rs10896854 | 0.83[CEU][hapmap] |
rs10896856 | 0.84[CEU][hapmap] |
rs10896857 | 0.84[CEU][hapmap] |
rs10896858 | 0.84[CEU][hapmap] |
rs10896859 | 0.84[CEU][hapmap] |
rs11229651 | 0.84[CEU][hapmap] |
rs11229655 | 0.84[CEU][hapmap] |
rs11229656 | 0.84[CEU][hapmap] |
rs11229658 | 0.84[CEU][hapmap] |
rs12225778 | 0.84[CEU][hapmap] |
rs12799196 | 0.82[AFR][1000 genomes];0.80[ASN][1000 genomes] |
rs17153009 | 0.83[CEU][hapmap] |
rs1938698 | 0.84[CEU][hapmap] |
rs1938701 | 0.87[CEU][hapmap] |
rs1938714 | 0.83[CEU][hapmap] |
rs1943280 | 0.84[CEU][hapmap] |
rs1943281 | 0.83[CEU][hapmap] |
rs1943282 | 0.84[CEU][hapmap] |
rs2156346 | 0.84[CEU][hapmap] |
rs2849855 | 0.85[ASN][1000 genomes] |
rs473287 | 0.84[CEU][hapmap] |
rs483101 | 0.83[CEU][hapmap];0.81[YRI][hapmap] |
rs488093 | 0.82[ASN][1000 genomes] |
rs4939226 | 0.84[CEU][hapmap] |
rs4939229 | 0.84[CEU][hapmap] |
rs4939230 | 0.84[CEU][hapmap] |
rs4939231 | 0.84[CEU][hapmap] |
rs497118 | 0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs507224 | 0.84[CEU][hapmap] |
rs533438 | 0.85[ASN][1000 genomes] |
rs550272 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs558274 | 0.88[CEU][hapmap] |
rs570146 | 0.84[CEU][hapmap] |
rs572006 | 0.84[CEU][hapmap] |
rs596847 | 0.84[CEU][hapmap];0.81[YRI][hapmap] |
rs599275 | 0.85[ASN][1000 genomes] |
rs608043 | 0.83[ASN][1000 genomes] |
rs615781 | 0.85[ASN][1000 genomes] |
rs620633 | 0.82[ASN][1000 genomes] |
rs644238 | 0.85[ASN][1000 genomes] |
rs645667 | 0.85[ASN][1000 genomes] |
rs658309 | 0.85[ASN][1000 genomes] |
rs667445 | 0.84[CEU][hapmap] |
rs678727 | 0.85[ASN][1000 genomes] |
rs7933339 | 1.00[JPT][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1050013 | chr11:58394598-59221090 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 67 gene(s) | inside rSNPs | diseases |
2 | nsv948365 | chr11:58515163-59156405 | Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Strong transcription Genic enhancers Enhancers Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 59 gene(s) | inside rSNPs | diseases |
3 | nsv1048605 | chr11:58534660-58672438 | Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
4 | nsv1045858 | chr11:58547772-58674568 | Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
5 | nsv1052173 | chr11:58553516-58678496 | Enhancers Weak transcription Bivalent/Poised TSS Active TSS ZNF genes & repeats Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
6 | esv3444895 | chr11:58614102-58779384 | Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
7 | nsv508634 | chr11:58624088-58657382 | Enhancers Weak transcription ZNF genes & repeats Strong transcription Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 2 gene(s) | inside rSNPs | diseases |
8 | esv1824025 | chr11:58626835-58669877 | Active TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
9 | esv1831269 | chr11:58626835-58669877 | Enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
10 | nsv528475 | chr11:58632368-58656808 | Enhancers ZNF genes & repeats Active TSS Weak transcription Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 2 gene(s) | inside rSNPs | diseases |
11 | esv1831555 | chr11:58632395-58653147 | Enhancers Weak transcription ZNF genes & repeats Strong transcription | TF binding regionCpG islandlncRNA | 1 gene(s) | inside rSNPs | diseases |
12 | esv3445007 | chr11:58638330-58709867 | Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Genic enhancers Strong transcription Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:58635000-58668000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr11:58645600-58652400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr11:58647600-58649000 | Enhancers | Liver | Liver |
4 | chr11:58647600-58649000 | Enhancers | HepG2 | liver |
5 | chr11:58648000-58654400 | Weak transcription | Fetal Lung | lung |
6 | chr11:58648000-58655000 | Weak transcription | Fetal Intestine Small | intestine |